TD Asset Management »

Silence Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $559k 31k 18.25

More positions owned by TD Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Broadcom (AVGO)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Canadian Pacific Kansas City (CP)
Cibc Cad (CM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Canadian Natural Resources (CNQ)

View all positions for TD Asset Management

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Lombard Odier Asset Management
Morgan Stanley
Frazier Life Sciences Management
Vivo Capital
Nantahala Capital Management
Polar Capital Holdings
Deep Track Capital
Nextech Invest
Eventide Asset Management
Point72 Asset Management
Bank of America Corporation
Woodline Partners

View all funds holding Silence Therapeutics